Researchers at Uppsala University have discovered a new class of antibiotics with potent activity against multi-drug resistant bacteria, and have shown that it cures bloodstream infections in mice. The new antibiotic class is described in a study recently published in the journal PNAS. Antibiotic
CRISPR already exists. This can easily be used to target antibiotic resistance genes and there are many examples in literature of this. Plasmid and phage as vector. Easy stuff. However, cane toads and wabbits and intentional release of GMOs leaves something to be desired for gene technology regulators.
Antibiotics are the way, but require targeted combination therapy, not a doctor’s gut feeling.